Portola Pharmaceuticals, Inc.

Part of Alexion Pharmaceuticals Inc.

UEI
FH2MKRASLYM3
CAGE
5XNN2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Website
alexion.com
Founded
1992
Employees
1K-5K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Portola Pharmaceuticals, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
SYK blockade in bullous skin diseases Grant · R43AR063129 National Institutes of Health $297,575
Prolonged and severe thrombocytopenia in neonates Grant · R44HL079701 National Institutes of Health -$422,650

Contract vehicles

Portola Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle. Active vehicles first.

Quick answers

What is Portola Pharmaceuticals, Inc.'s UEI?

Portola Pharmaceuticals, Inc.'s Unique Entity ID (UEI) in SAM.gov is FH2MKRASLYM3.

What is Portola Pharmaceuticals, Inc.'s CAGE code?

Portola Pharmaceuticals, Inc.'s CAGE code is 5XNN2.

What is Portola Pharmaceuticals, Inc.'s primary NAICS code?

Portola Pharmaceuticals, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Portola Pharmaceuticals, Inc. registered in SAM.gov?

Portola Pharmaceuticals, Inc.'s SAM.gov registration expired on November 17, 2022.

Who is Portola Pharmaceuticals, Inc.'s parent company?

Portola Pharmaceuticals, Inc. is part of Alexion Pharmaceuticals Inc.

Which contract vehicles does Portola Pharmaceuticals, Inc. hold?

Portola Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Portola Pharmaceuticals, Inc.'s most recent federal award?

Portola Pharmaceuticals, Inc.'s most recent federal grant award is SYK blockade in bullous skin diseases (R43AR063129), from National Institutes of Health, on September 1, 2012.

On GovTribe

See Portola Pharmaceuticals, Inc.'s full federal record

  • IDV awards
  • Contract vehicles
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login